David J. Woodhouse - 16 Jan 2024 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC

Signature
/s/ Valerie Pierce, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Jan 2024
Net transactions value
-$17,463
Form type
4
Filing time
18 Jan 2024, 18:01:27 UTC
Previous filing
08 Nov 2023
Next filing
08 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Tax liability $17,463 -13,032 -9% $1.34 131,822 16 Jan 2024 Direct F1
holding NGM Common Stock 80,000 16 Jan 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
F2 Shares held by The Woodhouse Family Trust 9/8/05.